Non-alcoholic fatty liver disease in patients with HCV genotype 4 [8]

Gut

Volumn 56, Issue 8, 2007, Pages 1170-1171

  El Zayadi, Abdel Rahman ^a,e   Attia, M ^b   Barakat, E M F ^a   Zalata, K ^c   Saeid, A ^d   Hamdy, H ^a   El Nakeeb, A ^d  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

^d Cairo Liver Center   (Egypt)

^e Cairo Liver Center ^*  (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY LIVER; GENOTYPE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOHISTOCHEMISTRY; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

EGYPT; FATTY LIVER; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 34547202444     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.123331     Document Type: Letter

References (5)

1. Nguyen MH, Keeffe EB. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol 2005;3:S97-S101.
2. Lonardo A, Adinolfi LE, Loria P, et al. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004;126:586-597.
3. Contos MJ, Sanyal AJ. The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol 2002;9:37-51.
4. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-1364.
5. Rubbia-Brandt L, Quadri R, Abid K, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000;33:106-115.